An underground market for unlicensed weight-loss medications is propelled by social media fitness personalities and sellers on communication apps, based on new investigations.
Experimental Drug Gaining Popularity Online
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are encouraged to message these accounts directly for source information, while also receiving discount codes.
Thriving Trade on Messaging Platforms
Separately, a robust trade exists on Telegram, where groups with thousands of participants share “before and after” images, administration instructions and assertions of next-day UK delivery. Vendors promote the drug there before redirecting buyers to WhatsApp for transactions.
Understanding Retatrutide
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.
Medical Experts Express Concerns
However, doctors and pharmacists have warned that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to users injecting products of unknown origin.
Several experts stated the popularity for the experimental drug could be connected to the rising cost of licensed weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or distributed for human use under the British medical regulations.
Some content creators try to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate pharmaceutical, marketing, and consumer regulations, risking penalties, legal action or imprisonment.
Platform Reaction and Material Removal
According to TikTok, the service has removed violative content and prohibited associated hashtags and query recommendations. The company stated it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.
Digital Trading Activities
Investigations also found groups with up to nine thousand participants marketing retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up channels with thousands of users, populated with images of slimming results, glowing testimonials and step-by-step instructions for preparing or injecting at residence.
After moments of entering one group, a seller shared contact information, where most transactions take place. The seller sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about weight, health issues or past usage.
Product Details and Pricing
Within these groups, messages show dark colored packages with Royal Mail labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors typically sold at £160 for 20 milligrams. When questioned how long a injector should be used, vendors give conflicting answers varying between a several days to “depends on your body”.
Platform Oversight and Security Actions
A representative for the messaging service stated it regularly moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting substances they cannot confirm. Even if the research behind this drug is valid, these digital versions may not include what they claim,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor connected the increase in interest to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.
Her team has previously encountered individuals injured by personal administration from unverified sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject users to potentially serious health risks”.
